Imugene Ltd
IMU
Company Profile
Business description
Imugene Ltd specializes in a clinical-stage immuno-oncology company. Its product includes HER-Vaxx,PD1-Vaxx, CF33 and CF33 CD19. HER-Vaxx is a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu. The company is also developing B-cell peptide cancer vaccines and therapeutics. Its only operating segment being the Research and Development of oncolytic immunotherapies.
Contact
4-6 Bligh Street
Suite 12.01, Level 12
Sydney NSW 2000
AUSSector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2024
Employees
5
Stocks News & Analysis
stocks
3 undervalued US growth shares with moats
Growth continues to capitivate investors but care should be taken to not overpay.
stocks
BHP lobs all-share proposal for Anglo American
Our view on the potential acquisition and what BHP gets with Anglo American
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,906.60 | 69.20 | 0.88% |
| CAC 40 | 8,065.15 | 23.09 | -0.29% |
| DAX 40 | 18,118.32 | 42.69 | -0.24% |
| Dow JONES (US) | 38,319.76 | 80.10 | 0.21% |
| FTSE 100 | 8,147.03 | 7.20 | 0.09% |
| HKSE | 17,746.91 | 95.76 | 0.54% |
| NASDAQ | 15,938.73 | 10.83 | 0.07% |
| Nikkei 225 | 37,934.76 | 306.28 | 0.81% |
| NZX 50 Index | 11,916.24 | 111.15 | 0.94% |
| S&P 500 | 5,102.19 | 2.23 | 0.04% |
| S&P/ASX 200 | 7,637.40 | 61.50 | 0.81% |
| SSE Composite Index | 3,113.04 | 24.41 | 0.79% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| The Star Entertainment Group Ltd SGR | 0.42 | 0.03 | 6.41% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | 0.00% |
| Droneshield Ltd DRO | 0.80 | 0.04 | -4.22% |
| Mesoblast Ltd MSB | 1.09 | 0.16 | 16.67% |
| South32 Ltd S32 | 3.51 | 0.14 | 4.15% |
| Pilbara Minerals Ltd PLS | 3.96 | 0.16 | 4.21% |
| Telstra Group Ltd TLS | 3.66 | 0.02 | 0.55% |
| Northern Minerals Ltd NTU | 0.03 | 0.00 | 6.25% |
| Jupiter Mines Ltd JMS | 0.32 | 0.02 | 5.00% |
| Imugene Ltd IMU | 0.08 | 0.00 | 3.80% |